Cargando…
Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway
OBJECTIVE: Ventral anterior homeobox 2 (VAX2) gene is a key regulating factor for the development of the ventral region of the eye, and has recently attracted much attention from the cancer treatment field. Our study aimed to explore the effect of VAX2 on papillary thyroid carcinoma (PTC). METHODS:...
Autores principales: | Guo, Bei, Zhang, Yi, Yuan, Kun, Jiang, Feng-Xia, Cui, Qian-Bo, Zhou, Qin, Dong, Hong-Xia, Chen, Wei, Yang, Shun-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874804/ https://www.ncbi.nlm.nih.gov/pubmed/33817157 http://dx.doi.org/10.1515/biol-2019-0027 |
Ejemplares similares
-
EIF1A depletion restrains human pituitary adenoma progression
por: Geng, Rongxin, et al.
Publicado: (2021) -
CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways
por: Yu, Shi-Tong, et al.
Publicado: (2018) -
FBXL6 depletion restrains clear cell renal cell carcinoma progression
por: Yu, Yongchun, et al.
Publicado: (2022) -
TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021) -
HealVax
por: Foerster, John, et al.
Publicado: (2018)